Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
09-11 June, 2026
World Vape ShowWorld Vape Show
Not Confirmed
Not Confirmed
09-11 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
09-11 June, 2026
World Vape ShowWorld Vape Show
Industry Trade Show
Not Confirmed
09-11 June, 2026
Digital content

08 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/08/3308149/0/en/adarx-pharmaceuticals-to-present-onvuzosiran-adx-324-phase-1-2-clinical-data-supporting-the-ongoing-phase-3-stop-hae-clinical-trial-at-the-2026-annual-eaaci-congress.html

24 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/24/3261341/0/en/ADARx-Pharmaceuticals-Expands-Leadership-Team-with-Appointment-of-Healthcare-Investment-Banking-Veteran-Ryan-Fisk-as-Chief-Financial-Officer-and-Chief-Business-Officer.html

27 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/27/3246430/0/en/ADARx-Pharmaceuticals-Presents-Onvuzosiran-Data-Supporting-Potential-for-Sustained-Attack-Free-Rates-with-Reduced-Treatment-Burden-in-Patients-with-HAE.html

05 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/05/3233074/0/en/ADARx-Pharmaceuticals-Appoints-Donald-Fong-M-D-as-Chief-Medical-Officer.html

02 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/02/3197991/0/en/ADARx-Pharmaceuticals-Appoints-Mary-Tagliaferri-M-D-to-its-Board-of-Directors.html

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3183820/0/en/ADARx-Pharmaceuticals-Announces-Positive-Interim-Phase-1-Clinical-Data-for-its-Novel-siRNA-Targeting-Complement-Factor-B-CFB.html
ABOUT THIS PAGE